These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1143089)

  • 1. Glucagon secretion in primary endogenous hypertriglyceridemia before and after clofibrate treatment.
    Tiengo A; Muggeo M; Assan R; Fedele D; Crepaldi G
    Metabolism; 1975 Aug; 24(8):901-14. PubMed ID: 1143089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of clofibrate treatment on arginine-induced insulin secretion in endogenous hypertriglyceridemia.
    Fedele D; Tiengo A; Muggeo M; Nosadini R; Crepaldi G
    Atherosclerosis; 1976; 25(2-3):191-8. PubMed ID: 1008908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of clofibrate on glucose tolerance and insulin secretion in patients with endogenous hypertriglyceridemia (author's transl)].
    Schwandt P; Weisweiler P; Neureuther G; Wilkening J
    MMW Munch Med Wochenschr; 1976 Mar; 118(12):351-4. PubMed ID: 177863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of obesity on the relationship between insulin and triglyceride levels in endogenous hypertriglyceridemia.
    Bagdade JD; Bierman EL; Porte D
    Diabetes; 1971 Oct; 20(10):664-72. PubMed ID: 5110698
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of clofibrate on arginine-stimulated glucagon and insulin secretion in man.
    Eaton RP; Schade DS
    Metabolism; 1974 May; 23(5):445-54. PubMed ID: 4825301
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of contraceptive steroids on arginine-stimulated glucagon and insulin secretion in women. III. Medroxyprogesterone acetate.
    Beck P; Zimmerman DE; Eaton RP
    Metabolism; 1977 Nov; 26(11):1193-8. PubMed ID: 909395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone secretion in primary endogenous hypertriglyceridemia.
    Muggeo M; Fedele D; Tiengo A; Crepaldi G
    Horm Metab Res; 1973 May; 5(3):224-5. PubMed ID: 4714551
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic effects of glucagon in endogenous hypertriglyceridemia.
    Nosadini R; Soldà G; de Biasi F; Tiengo A
    Acta Diabetol Lat; 1978; 15(5-6):251-8. PubMed ID: 219650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of clofibrate on arginine-induced insulin and glucagon secretion.
    Eaton RP
    Metabolism; 1973 Jun; 22(6):763-7. PubMed ID: 4350845
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic effects of clofibrate in insulin-dependent ketosis-prone diabetic man.
    Schade DS; Eaton RP; George S; Conway M; Kaminsky N; Sivinski J
    Metabolism; 1978 Apr; 27(4):461-8. PubMed ID: 416322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of short-term clofibrate administration on glucose tolerance and insulin secretion in patients with chemical diabetes or hypertriglyceridemia.
    Ferrari C; Frezzati S; Romussi M; Bertazzoni A; Testori GP; Antonini S; Paracchi A
    Metabolism; 1977 Feb; 26(2):129-39. PubMed ID: 834147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of clofibrate therapy on glucose tolerance, insulin secretion and serum lipids in subjects with hyperlipoproteinemia and impaired glucose tolerance. A follow-up study over a five-year period.
    Ratzmann ML; Rjasanowski I; Bruns W; Ratzmann KP
    Exp Clin Endocrinol; 1983 Aug; 82(2):216-21. PubMed ID: 6354731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of clofibrate therapy on the glucagon and insulin secretion as well as on the glucose tolerance in patients with type IV hyperlipoproteinemia].
    Drost H; Grüneklee D; Korthaus G; Gries FA
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():835-8. PubMed ID: 1029295
    [No Abstract]   [Full Text] [Related]  

  • 14. Clofibrate-induced changes in glucagon and insulin secretion in patients with angiographically documented coronary artery disease.
    Eaton RP; Schade DS; Lueker R
    Am J Clin Nutr; 1977 Dec; 30(12):2068-77. PubMed ID: 930877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of clofibrate on plasma glucose and serum immunoreactive insulin in patients with hyperlipoproteinemia.
    Fenderson RW; Sekowski I; Mohan C; Deutsch S; Benjamin F; Samuel P
    Am J Clin Nutr; 1974 Jan; 27(1):22-8. PubMed ID: 4809201
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of short-term administration of clofibrate on insulin and glucagon response to protein ingestion in man.
    Fery F; Balasse EO
    Arch Int Pharmacodyn Ther; 1978 Oct; 235(2):341-50. PubMed ID: 736705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of insulin and glucagon secretions in severely burned patients.
    Shuck JM; Eaton P; Shuck LW; Wachtel TL; Schade DS
    J Trauma; 1977 Sep; 17(9):706-13. PubMed ID: 894760
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of clofibrate on glucose tolerance, insulin secretion, triglycerides and fibrinogen in patients with coronary heart disease.
    Enger SC; Johnsen V; Samuelsen A; Laws EA
    Acta Med Scand; 1977; 201(6):563-6. PubMed ID: 327758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased glucose disappearance rate after short-term clofibrate administration in normal subjects and in patients with chemical diabetes.
    Ferrari C; Testori GP; Bertazzoni A; Romussi M; Caldara R; Frezzati S
    Horm Metab Res; 1978 Jan; 10(1):4-6. PubMed ID: 631736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of contraceptive steroids on arginine-stimulated glucagon and insulin secretion in women: I-Lipid physiology.
    Beck P; Eaton RP; Arnett DM; Alsever RN
    Metabolism; 1975 Sep; 24(9):1055-65. PubMed ID: 1152675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.